Selenium and prostate cancer prevention: What next - If anything?

Cancer Prevention Research

Volumn 7, Issue 8, 2014, Pages 781-785

  Christensen, Merrill J ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM; SELENOPROTEIN; BIOLOGICAL MARKER; SELENOMETHIONINE;

ANGIOGENESIS; APOPTOSIS; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; DIET SUPPLEMENTATION; DNA REPAIR; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PUBLIC HEALTH; REVIEW; RISK REDUCTION; SELENIUM BLOOD LEVEL; TUMOR IMMUNITY; DRUG EFFECTS; MALE; METABOLISM;

BIOLOGICAL MARKERS; HUMANS; MALE; OXIDATIVE STRESS; SELENIUM; SELENOMETHIONINE;

EID: 84905824259     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0197     Document Type: Review

References (42)

1. Eisinger F, Cancel-Tassin G, Azzouzi AR, Gravis G, Rossi D, Cussenot O. Pharmaco and diet based prostate cancer prevention. Bull Cancer 2013;100:497-507.
2. Dennert G, Zwahlen M, Brinkman M, Vinceti M, Zeegers MP, Horneber M. Selenium for preventing cancer. Cochrane Database Syst Rev 2011:CD005195.
3. Hurst R, Hooper L, Norat T, Lau R, Aune D, Greenwood DC, et al. Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr 2012;96:111-22.
4. Vinceti M, Dennert G, Crespi CM, Zwahlen M, Brinkman M, Zeegers MP, et al. Selenium for preventing cancer. Cochrane Database Syst Rev 2014;3:CD005195.
5. Quiner TE, Nakken HL, Mason BA, Lephart ED, Hancock CR, Christensen MJ. Soy content of basal diets determines the effects of supplemental selenium in male mice. J Nutr 2011;141:2159-65.
6. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 2003;91:608-12. (Pubitemid 36583728)
7. Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306:1549-56.
8. Marshall JR, Tangen CM, Sakr WA, Wood DP Jr, Berry DL, Klein EA, et al. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res 2011;4:1761-9.
9. Algotar AM, Stratton MS, Ahmann FR, Ranger-Moore J, Nagle RB, Thompson PA, et al. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate 2013;73:328-35.
10. Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, et al. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst 2014;106:djt456.
11. Waters DJ, Shen S, Glickman LT, Cooley DM, Bostwick DG, Qian J, et al. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis 2005;26:1256-62. (Pubitemid 41417903)
12. Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med 2008;168:404-10. (Pubitemid 351347132)
13. Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-24. (Pubitemid 28407088)
14. Geybels MS, van den Brandt PA, Schouten LJ, van Schooten FJ, van Breda SG, Rayman MP, et al. Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer. J Natl Cancer Inst 2014;106:dju003.
15. Pinto JT, Sinha R, Papp K, Facompre ND, Desai D, El-Bayoumy K. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells. Int J Cancer 2007;120:1410-7. (Pubitemid 46355374)
16. Abdulah R, Kobayashi K, Yamazaki C, Koyama H. Molecular targets of selenium in prostate cancer prevention (Review). Int J Oncol 2011;39:301-9.
17. Li GX, Lee HJ, Wang Z, Hu H, Liao JD, Watts JC, et al. Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 2008;29:1005-12. (Pubitemid 351982246)
18. Zhang J, Wang L, Li G, Anderson LB, Xu Y, Witthuhn B, et al. Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds. Nutr Cancer 2011;63:778-89.
19. Richie JP Jr, Das A, Calcagnotto AM, Sinha R, Neidig W, Liao J, et al. Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial. Cancer Prev Res 2014;3:796-804.
20. Hurst R, Collings R, Harvey LJ, King M, Hooper L, Bouwman J, et al. EURRECA-Estimating selenium requirements for deriving dietary reference values. Crit Rev Food Sci Nutr 2013;53:1077-96.
21. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, et al. Characterization of mammalian selenoproteomes. Science 2003;300:1439-43. (Pubitemid 36638165)
22. Squires JE, Berry MJ. Eukaryotic selenoprotein synthesis: mechanistic insight incorporating new factors and new functions for old factors. IUBMB Life 2008;60:232-5.
23. Institute of Medicine. Selenium. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, D.C.: National Academy Press; 2000. p. 284-324.
24. Xia Y, Hill KE, Byrne DW, Xu J, Burk RF. Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 2005;81:829-34. (Pubitemid 41724990)
25. Combs GF Jr, Watts JC, Jackson MI, Johnson LK, Zeng H, Scheett AJ, et al. Determinants of selenium status in healthy adults. Nutr J 2011;10:75.
26. Hill KE, Xia Y, Akesson B, Boeglin ME, Burk RF. Selenoprotein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects. J Nutr 1996; 126:138-45. (Pubitemid 26032214)
27. Burk RF, Norsworthy BK, Hill KE, Motley AK, Byrne DW. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev 2006;15:804-10.
28. Burk RF, Hill KE, Motley AK. Plasma selenium in specific and non-specific forms. Biofactors 2001;14:107-14. (Pubitemid 32848305)
29. Garcia-Sevillano MA, Garcia-Barrera T, Gomez-Ariza JL. Development of a new column switching method for simultaneous speciation of selenometabolites and selenoproteins in human serum. J Chromatogr A 2013;1318:171-9.
30. Gu QP, Xia YM, Ha PC, Butler JA, Whanger PD. Distribution of selenium between plasma fractions in guinea pigs and humans with various intakes of dietary selenium. J Trace Elem Med Biol 1998;12:8-15. (Pubitemid 28241842)
31. Harrison I, Littlejohn D, Fell GS. Distribution of selenium in human blood plasma and serum. Analyst 1996;121:189-94. (Pubitemid 26082021)
32. Jeong JS, Lee J, Park YN. Quantitative speciation of selenium in human blood serum and urine with AE- RP- and AF-HPLC-ICP/MS. Bull Korean Chem Soc 2013;34:3817-24.
33. Reyes LH, Marchante-Gayon JM, Alonso JIG, Sanz-Medel A. Quantitative speciation of selenium in human serum by af finity chromatography coupled to post-column isotope dilution analysis ICP-MS. J Anal At Spectrom 2003;18:1210-6.
34. Xia Y, Ha P, Hill K, Butler J, Whanger P. Distribution of selenium between fractions in erythrocytes, plasma, hair, and fingernails of Chinese women living in selenium-deficient, -adequate, and -excessive areas of China. J Trace Elem Exp Med 2000;13:333-42.
35. Solovyev N, Berthele A, Michalke B. Selenium speciation in paired serum and cerebrospinal fluid samples. Anal Bioanal Chem 2013;405:1875-84.
36. Irons R, Carlson BA, Hatfield DL, Davis CD. Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J Nutr 2006;136:1311-7.
37. Rayman MP, Infante HG, Sargent M. Food-chain selenium and human health: spotlight on speciation. Br J Nutr 2008;100:238-53.
38. Wang L, Bonorden MJ, Li GX, Lee HJ, Hu H, Zhang Y, et al. Methylselenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev Res 2009;2:484-95.
39. Laclaustra M, Stranges S, Navas-Acien A, Ordovas JM, Guallar E. Serum selenium and serum lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Atherosclerosis 2010;210:643-8.
40. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51.
41. Vinceti M, Crespi CM, Malagoli C, Giovane CD, Krogh V. Friend or foe? The current epidemiolgic evidence on selenium and human cancer risk. J Environ Sci Heal C 2013;31:305-41.
42. Meplan C, Rohrmann S, Steinbrecher A, Schomburg L, Jansen E, Linseisen J, et al. Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer. PLoS ONE 2012;7:e48709.